{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Clinical and economic evaluation of alemtuzumab compared to ocrelizumab in the treatment of relapsing forms of multiple sclerosis in the United States: a payer perspective", "pub_year": 2017, "citation": "MULTIPLE SCLEROSIS JOURNAL 23, 885-885, 2017", "author": "V Chirikov and I Ma and N Joshi and D Patel and A Smith and C Giambrone and N Cornelio and L Hashemi", "conference": "MULTIPLE SCLEROSIS JOURNAL", "volume": "23", "pages": "885-885", "publisher": "SAGE PUBLICATIONS LTD"}, "filled": true, "author_pub_id": "mSp4V_4AAAAJ:M3hCyctIOBoC", "num_citations": 0, "pub_url": "https://scholar.google.com/scholar?cluster=7726369061872905837&hl=en&oi=scholarr", "cites_per_year": {}}